File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jad.2024.01.264
- Scopus: eid_2-s2.0-85184816433
- PMID: 38309479
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization
Title | Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization |
---|---|
Authors | |
Issue Date | 2024 |
Citation | Journal of Affective Disorders, 2024, v. 351, p. 853-862 How to Cite? |
Abstract | Aims: Cannabis use may increase the risk of self-harm, but whether legalization of cannabis is associated with changes in self-harm is unknown. We examined changes in cannabis-involvement in emergency department (ED) visits for self-harm after the liberalization of medical and legalization of non-medical cannabis in Canada. Methods: This repeated cross-sectional study used health administrative data to identify all ED visits for self-harm in individuals aged ten and older between January 2010 and December 2021. We identified self-harm ED visits with a co-diagnosis of cannabis (main exposure) or alcohol (control condition) and examined changes in rates of visits over four distinct policy periods (pre-legalization, medical liberalization, non-medical legalization with restrictions, and non-medical commercialization/COVID-19) using Poisson models. Results: The study included 158,912 individuals with one or more self-harm ED visits, of which 7810 (4.9 %) individuals had a co-diagnosis of cannabis use and 24,761 (15.6 %) had a co-diagnosis of alcohol use. Between 2010 and 2021, the annual rate of ED visits for self-harm injuries involving cannabis per 100,000 individuals increased by 90.1 % (3.6 in 2010 to 6.9 in 2021 per 100,000 individuals), while the annual rate of self-harm injuries involving alcohol decreased by 17.3 % (168.1 in 2010 to 153.1 in 2021 per 100,000 individuals). The entire increase in visits relative to pre-legalization occurred after medical liberalization (seasonally adjusted Risk Ratio [asRR] 1.71 95 % CI 1.09–1.15) with no further increases during the legalization with restrictions (asRR 1.77 95%CI 1.62–1.93) or commercialization/COVID-19 periods (asRR 1.63 95%CI 1.50–176). Conclusions: Cannabis-involvement in self-harm ED visits almost doubled over 12 years and may have accelerated after medical cannabis liberalization. While the results cannot determine whether cannabis is increasingly causing self-harm ED visits or whether cannabis is increasingly being used by individuals at high risk of self-harm, greater detection for cannabis use in this population and intervention may be indicated. |
Persistent Identifier | http://hdl.handle.net/10722/347093 |
ISSN | 2023 Impact Factor: 4.9 2023 SCImago Journal Rankings: 2.082 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Myran, Daniel T. | - |
dc.contributor.author | Gaudreault, Adrienne | - |
dc.contributor.author | Pugliese, Michael | - |
dc.contributor.author | Tanuseputro, Peter | - |
dc.contributor.author | Saunders, Natasha | - |
dc.date.accessioned | 2024-09-17T04:15:20Z | - |
dc.date.available | 2024-09-17T04:15:20Z | - |
dc.date.issued | 2024 | - |
dc.identifier.citation | Journal of Affective Disorders, 2024, v. 351, p. 853-862 | - |
dc.identifier.issn | 0165-0327 | - |
dc.identifier.uri | http://hdl.handle.net/10722/347093 | - |
dc.description.abstract | Aims: Cannabis use may increase the risk of self-harm, but whether legalization of cannabis is associated with changes in self-harm is unknown. We examined changes in cannabis-involvement in emergency department (ED) visits for self-harm after the liberalization of medical and legalization of non-medical cannabis in Canada. Methods: This repeated cross-sectional study used health administrative data to identify all ED visits for self-harm in individuals aged ten and older between January 2010 and December 2021. We identified self-harm ED visits with a co-diagnosis of cannabis (main exposure) or alcohol (control condition) and examined changes in rates of visits over four distinct policy periods (pre-legalization, medical liberalization, non-medical legalization with restrictions, and non-medical commercialization/COVID-19) using Poisson models. Results: The study included 158,912 individuals with one or more self-harm ED visits, of which 7810 (4.9 %) individuals had a co-diagnosis of cannabis use and 24,761 (15.6 %) had a co-diagnosis of alcohol use. Between 2010 and 2021, the annual rate of ED visits for self-harm injuries involving cannabis per 100,000 individuals increased by 90.1 % (3.6 in 2010 to 6.9 in 2021 per 100,000 individuals), while the annual rate of self-harm injuries involving alcohol decreased by 17.3 % (168.1 in 2010 to 153.1 in 2021 per 100,000 individuals). The entire increase in visits relative to pre-legalization occurred after medical liberalization (seasonally adjusted Risk Ratio [asRR] 1.71 95 % CI 1.09–1.15) with no further increases during the legalization with restrictions (asRR 1.77 95%CI 1.62–1.93) or commercialization/COVID-19 periods (asRR 1.63 95%CI 1.50–176). Conclusions: Cannabis-involvement in self-harm ED visits almost doubled over 12 years and may have accelerated after medical cannabis liberalization. While the results cannot determine whether cannabis is increasingly causing self-harm ED visits or whether cannabis is increasingly being used by individuals at high risk of self-harm, greater detection for cannabis use in this population and intervention may be indicated. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Affective Disorders | - |
dc.title | Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.jad.2024.01.264 | - |
dc.identifier.pmid | 38309479 | - |
dc.identifier.scopus | eid_2-s2.0-85184816433 | - |
dc.identifier.volume | 351 | - |
dc.identifier.spage | 853 | - |
dc.identifier.epage | 862 | - |
dc.identifier.eissn | 1573-2517 | - |